Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Environmental Science and Technology

• Publication date

  2015-09-11

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1021/acs.est.5b02489PMID 26333069PMCID PMC4638415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)

  2015cited by this paper
• Temporal trends (1999-2010) of perfluoroalkyl acids in commonly consumed food items.

  2014cited by this paper
• Invited commentary: interpreting associations between exposure biomarkers and pregnancy outcome.

  2014cited by this paper
• Maternal Glomerular Filtration Rate in Pregnancy and Fetal Size

  2014cited by this paper
• Changes in Serum Concentrations of Maternal Poly- and Perfluoroalkyl Substances over the Course of Pregnancy and Predictors of Exposure in a Multiethnic Cohort of Cincinnati, Ohio Pregnant Women during 2003–2006

  2014cited by this paper
• Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.

  2014cited by this paper
• Contribution of diet and other factors to the levels of selected polyfluorinated compounds: data from NHANES 2003-2008.

  2014cited by this paper
• Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.

  2013cited by this paper
• Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum.

  2013cited by this paper
• Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds

  2013cited by this paper
• Polyfluorinated compounds in serum linked to indoor air in office environments.

  2012cited by this paper
• Dietary exposure to perfluoroalkyl acids for the Swedish population in 1999, 2005 and 2010.

  2012cited by this paper
• Understanding Differences in the Body Burden–Age Relationships of Bioaccumulating Contaminants Based on Population Cross Sections versus Individuals

  2012cited by this paper
• Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals.

  2011cited by this paper
• Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

  2011cited by this paper
• Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study.

  2010cited by this paper
• Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy

  2010cited by this paper
• Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals

  2009cited by this paper
• Predictors of PFOA Levels in a Community Surrounding a Chemical Plant

  2009cited by this paper
• Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain.

  2009cited by this paper
• The C8 Health Project: Design, Methods, and Participants

  2009cited by this paper
• Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia

  2009cited by this paper
• Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.

  2009cited by this paper
• Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds.

  2008cited by this paper
• Dietary predictors of perfluorinated chemicals: a study from the Danish National Birth Cohort.

  2008cited by this paper
• Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

  2007cited by this paper
• Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers

  2007cited by this paper
• Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000

  2007cited by this paper
• Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland.

  2007cited by this paper
• Temporal trends

  2005cited by this paper
• Lipid Adjustment in the Analysis of Environmental Contaminants and Human Health Risks

  2005cited by this paper
• The developmental toxicity of perfluoroalkyl acids and their derivatives.

  2004cited by this paper
• Binding of perfluorooctanoic acid to rat and human plasma proteins.

  2003cited by this paper
• Cohort Profile Cohort Profile: Project Viva

  year unknowncited by this paper

• Developmental nephrotoxicity of per- and polyfluoroalkyl substances: Mechanistic insights and epidemiological evidence from prenatal and early-life exposure.

  2026cites this paper
• Unraveling Plastic-Related Chemical Exposures during Pregnancy and Their Associations with Pregnancy Outcomes Using Suspect Screening Analysis

  2026cites this paper
• Quantifying PFAS-Omics Burden Scores for Nontargeted Analysis Using Multidimensional Item Response Theory: An Exploratory Analysis of Novel and Legacy PFAS in Cord Blood.

  2026cites this paper
• Prenatal exposure to endocrine-disrupting chemicals and childhood atopic dermatitis: epidemiological evidence

  2025cites this paper
• Fracture-mediated transport and bio-mineral synergistic attenuation of PFOA plumes: Implications prediction for reactive remediation in heterogeneous field coupling with various groundwater environment.

  2025cites this paper
• Advancing the understanding of PFAS-induced reproductive toxicity in key model species.

  2025cites this paper
• Associations of PFOA and PFOS Exposure with Liver Injury: Evidence from the Dongfeng-Tongji Cohort, NHANES 2003-2018, and Integrative Adverse Outcome Pathway Analysis.

  2025cites this paper
• Endocrine Disrupting Chemicals and Female Sexual Health: An Emerging Research Priority.

  2025cites this paper
• Exposure to per- and polyfluoroalkyl substances during fetal development and risk of testicular germ cell cancer in adulthood

  2025cites this paper
• High-resolution source apportionment and spatiotemporal drivers of per- and polyfluoroalkyl substances (PFAS) across China's largest river-estuary continuum: Toward sustainable management of emerging contaminants.

  2025cites this paper
• Short-chain per- and polyfluoroalkyl substances associate with elevated alanine aminotransferase: Cross-sectional analysis results from the STRIVE cohort.

  2025cites this paper
• Levels and determinants of exposure to perfluoroalkyl substances in French pregnant women from the SEPAGES cohort.

  2025cites this paper
• Comprehensive Risk Evaluation of Perfluoroalkyl Substance Pollution in Urban Riverine Systems: Ecotoxicological and Human Health Perspectives

  2025cites this paper
• Exposure to Legacy Per- and Polyfluoroalkyl Substances from Diet and Drinking Water in California Adults, 2018–2020

  2025cites this paper
• Per- and Polyfluoroalkyl Substances in Eutopic Endometrium Tissue and Risk of Endometriosis: Findings from the Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) Study

  2025cites this paper
• PFOS Exposure Impairs Porcine Oocyte Maturation and Embryo Development via Mitochondria-Dependent Ferroptosis.

  2025cites this paper
• Determinants of plasma poly- and perfluoroalkyl substances during pregnancy: The Japan Environment and Children's Study.

  2025cites this paper
• Prenatal Concentrations of Perfluoroalkyl Substances and Maternal Beta Cell Function at 7 to 9 Years of Follow-Up.

  2025cites this paper
• Assessment of per- and polyfluoroalkyl substances (PFAS) exposure and associations with oxidative stress biomarkers among pregnant women from the PROTECT cohort.

  2025cites this paper
• Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in Project Viva.

  2025cites this paper
• Early‐pregnancy per‐ and polyfluoroalkyl substances and maternal post‐pregnancy weight trajectory

  2025cites this paper
• Does the timing of sample collection confound the association between prenatal serum PFAS concentrations and birthweight: results from two prospective cohort studies.

  2025cites this paper
• Exploring the initial bond activations of PFAS on zero-valent iron.

  2025cites this paper
• First trimester plasma per- and polyfluoroalkyl substances (PFAS) and blood pressure trajectories across the second and third trimesters of pregnancy

  2024cites this paper
• Rapid and effective removal of PFOS from water using ultrathin MgAl-LDH nanosheets with defects

  2024cites this paper
• Perfluoroalkylated substances – an endocrine disruptor with reprotoxic effects

  2024cites this paper
• Associations between Per- and Polyfluoroalkyl Substances (PFAS) and Female Sexual Function in a Preconception Cohort.

  2024cites this paper
• Understanding prenatal household exposures to per- and polyfluorylalkyl substances using paired Biological and dust measurements with sociodemographic and housing variables

  2024cites this paper
• Clinical, histological, molecular, and toxicokinetic renal outcomes of per-/polyfluoroalkyl substances (PFAS) exposure: Systematic review and meta-analysis.

  2024cites this paper
• Per- and polyfluoroalkyl substances (PFAS): Trends in mass spectrometric analysis for human biomonitoring and exposure patterns from recent global cohort studies.

  2024cites this paper
• A Prospective Analysis of Per- and Polyfluoroalkyl Substances from Early Pregnancy to Delivery in the Atlanta African American Maternal–Child Cohort

  2024cites this paper
• Legacy and Novel Per- and Polyfluoroalkyl Substances in Surface Soils across China: Source Tracking and Main Drivers for the Spatial Variation

  2024cites this paper
• Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity.

  2024cites this paper
• Pregnancy complications and birth outcomes following low-level exposure to per- and polyfluoroalkyl substances in the vitamin D antenatal asthma reduction trial

  2024cites this paper
• Prenatal blood metals, per- and polyfluoroalkyl substances and antigen- or mitogen-stimulated cord blood lymphocyte proliferation and cytokine secretion.

  2024cites this paper
• Associations of per- and polyfluoroalkyl substances with uterine leiomyomata incidence and growth: a prospective ultrasound study

  2024cites this paper
• Exogenous factors associated with legacy PFAS concentrations in the general U.S. population: NHANES 1999-2018

  2024cites this paper
• Human biomonitoring follow-up study on PFOA contamination and investigation of possible influencing factors on PFOA exposure in a German population originally exposed to emissions from a fluoropolymer production plant.

  2024cites this paper
• Invited Perspective: Per- and Polyfluoroalkyl Substances in Drinking Water—Disparities in Community Exposures Based on Race and Socioeconomic Status

  2024cites this paper
• Quantifying Disparities in Per- and Polyfluoroalkyl Substances (PFAS) Levels in Drinking Water from Overburdened Communities in New Jersey, 2019–2021

  2024cites this paper
• Associations of Serum Perfluoroalkyl Substances and Placental Human Chorionic Gonadotropin in Early Pregnancy, Measured in the UPSIDE Study in Rochester, New York

  2024cites this paper
• Exploring the impact of prenatal perfluoroalkyl and polyfluoroalkyl substances exposure on blood pressure in early childhood: A longitudinal analysis.

  2024cites this paper
• Exploring the Potential Link between PFAS Exposure and Endometrial Cancer: A Review of Environmental and Sociodemographic Factors

  2024cites this paper
• Prenatal exposure to poly- and perfluoroalkyl substances and postpartum depression in women with twin pregnancies.

  2024cites this paper
• Maternal Exposure to Per- and Polyfluoroalkyl Substances: Implications for Intrahepatic Cholestasis of Pregnancy and Adverse Birth Outcomes

  2024cites this paper
• What Can Blyholder Teach Us About PFAS Degradation on Metal Surfaces?

  2024cites this paper
• Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014–2016 and comparison with the National Health and Nutrition Examination Survey (NHANES)

  2023cites this paper
• Geographic and demographic variability in serum PFAS concentrations for pregnant women in the United States

  2023cites this paper
• Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy.

  2023cites this paper
• Perfluorooctanoic acid (PFOA) exposure induces renal filtration and reabsorption disorders via downregulation of aquaporins.

  2023cites this paper
• Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study

  2023cites this paper
• Porous polypyrrole with a vesicle-like structure for efficient removal of per- and polyfluoroalkyl substances from water: Crucial role of porosity and morphology.

  2023cites this paper
• Factors associated with per- and polyfluoroalkyl substances (PFAS) serum concentrations in residents of New Hanover County, North Carolina: The GenX exposure study.

  2023cites this paper
• Exposure to per- and polyfluoroalkyl substances in women with twin pregnancies: Patterns and variability, transplacental transfer, and predictors.

  2023cites this paper
• Prenatal and Childhood Per‐ and Polyfluoroalkyl Substance (PFAS) Exposures and Blood Pressure Trajectories From Birth to Late Adolescence in a Prospective US Prebirth Cohort

  2023cites this paper
• Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014–2016 and comparison with the National Health and Nutrition Examination Survey (NHANES)

  2023cites this paper
• Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.

  2023cites this paper
• Research Progress on Neurodevelopmental Toxicity in Offspring after Indirect Exposure to PFASs in Early Life

  2023cites this paper
• Domestic Dogs and Horses as Sentinels of Per- and Polyfluoroalkyl Substance Exposure and Associated Health Biomarkers in Gray's Creek North Carolina.

  2023cites this paper
• Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.

  2023cites this paper
• Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003–16): an observational study

  2023cites this paper
• Maternal Serum, Cord and Human Milk Levels of Per- and Polyfluoroalkyl Substances (PFAS), Association with Predictors and Effect on Newborn Anthropometry

  2023cites this paper
• Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort.

  2023cites this paper
• Determinants of maternal and neonatal PFAS concentrations: a review

  2023influential citation
• Association between serum levels of TSH and free T4 and per- and polyfluoroalkyl compounds concentrations in pregnant women.

  2023cites this paper
• Dietary and maternal sociodemographic determinants of perfluoroalkyl and polyfluoroalkyl substance levels in pregnant women.

  2023cites this paper
• Exposure to perfluoroalkyl and polyfluoroalkyl substances and estimated glomerular filtration rate in adults: a cross-sectional study based on NHANES (2017–2018)

  2023cites this paper
• Legacy perfluoroalkyl acids and their oxidizable precursors in plasma samples of Norwegian women.

  2023cites this paper
• A Sharper Focus: Clarifying the PFAS–Preeclampsia Association by Analyzing Disease Subtypes

  2022cites this paper
• Exposure of Preconception Couples to Legacy and Emerging Per- and Polyfluoroalkyl Substances: Variations Within and Between Couples.

  2022cites this paper
• Association between maternal per- and polyfluoroalkyl substance exposure and newborn telomere length: Effect modification by birth seasons.

  2022cites this paper
• Perfluorooctanoate and perfluorooctane sulfonate in umbilical cord blood and child cognitive development: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).

  2022cites this paper
• Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort

  2022cites this paper
• Prenatal Perfluorooctanoic Acid (PFOA) Exposure Is Associated With Lower Infant Birthweight Within the MADRES Pregnancy Cohort

  2022cites this paper
• Atomistic insights into the hydrodefluorination of PFAS using silylium catalysts.

  2022cites this paper
• Association of maternal perfluoroalkyl substance exposure with postpartum haemorrhage in Guangxi, China.

  2022cites this paper
• PFAS levels and determinants of variability in exposure in European teenagers – Results from the HBM4EU aligned studies (2014–2021)

  2022cites this paper
• The effects of endocrine‐disrupting chemicals on ovarian‐ and ovulation‐related fertility outcomes

  2022cites this paper
• PFAS levels and exposure determinants in sensitive population groups.

  2022cites this paper
• Concentrations of Per- and Polyfluoroalkyl Substances in Paired Maternal Plasma and Human Milk in the New Hampshire Birth Cohort

  2022cites this paper
• Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Childhood Autism-related Outcomes

  2022cites this paper
• Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts

  2021cites this paper
• Mixture effects of prenatal exposure to per- and polyfluoroalkyl substances and polybrominated diphenyl ethers on maternal and newborn telomere length

  2021cites this paper
• Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems

  2021influential citation
• Serum levels of perfluorooctanoic acid and perfluorooctane sulfonic acid in pregnant women: Maternal predictors and associations with birth outcomes in the PIPA Project

  2021cites this paper
• Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.

  2021cites this paper
• Association between gestational PFAS exposure and Children's adiposity in a diverse population.

  2021cites this paper
• Per-and polyfluoroalkyl substances (PFAS) and persistent chemical mixtures in dust from U.S. colleges.

  2021cites this paper
• Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants.

  2021cites this paper
• Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.

  2021cites this paper
• Per- and Poly-fluoroalkyl Substances (PFAS) and Female Reproductive Outcomes: PFAS Elimination, Endocrine-Mediated Effects, and Disease.

  2021cites this paper
• Remediation of per- and polyfluoroalkyls (PFAs) via electrochemical methods

  2021cites this paper
• Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk

  2021cites this paper
• Joint effects of prenatal exposure to per- and poly-fluoroalkyl substances and psychosocial stressors on corticotropin-releasing hormone during pregnancy

  2021cites this paper
• Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition from Mid-childhood to Early Adolescence.

  2021cites this paper
• Correlates of Persistent Endocrine-Disrupting Chemical Mixtures among Reproductive-Aged Black Women.

  2021cites this paper
• Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: Recent findings from NHANES 1999-2016.

  2021cites this paper
• Magnetic ion-exchange (MIEX) resin for perfluorinated alkylsubstance (PFAS) removal in groundwater: Roles of atomic charges for adsorption.

  2020cites this paper
• Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial.

  2020cites this paper
• Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort

  2020cites this paper